SUBSCRIBE
SUBSCRIBE

Quoin Pharmaceuticals

IN THE PRESS
Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study
May 15, 2025
 · 
6 min read
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results
May 13, 2025
 · 
9 min read
Quoin Pharmaceuticals to Announce First Quarter 2025 Financial Results on Tuesday, May 13, 2025
May 7, 2025
 · 
1 min read
Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
April 30, 2025
 · 
3 min read
Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign
April 10, 2025
 · 
7 min read
Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
April 2, 2025
 · 
6 min read
Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases
March 26, 2025
 · 
5 min read
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
March 13, 2025
 · 
10 min read
Quoin Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on Thursday, March 13, 2025
March 6, 2025
 · 
1 min read
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications
March 4, 2025
 · 
8 min read
JOBS